We are live on ! Find out more
SCA

Sippican Capital Advisors Portfolio holdings

AUM $164M
1-Year Est. Return 35.17%
This Fund
S&P 500
This Quarter Est. Return
+0.9%
1 Year Est. Return
+35.17%
3 Year Est. Return
+90.08%
5 Year Est. Return
+122.79%
10 Year Est. Return
+440.32%
AUM
$105M
AUM Growth
+$62.5K
Cap. Flow
+$1.82M
Cap. Flow %
1.74%
Top 10 Hldgs %
25.71%
Holding
104
New
5
Increased
26
Reduced
40
Closed
4

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$670K
2
TROW icon
T. Rowe Price
TROW
+$665K
3
APLS
Apellis Pharmaceuticals
APLS
+$644K
4
GEHC icon
GE HealthCare
GEHC
+$575K
5
TFIN icon
Triumph Financial Inc
TFIN
+$546K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$640K
2
GE icon
GE Aerospace
GE
+$524K
3
GILD icon
Gilead Sciences
GILD
+$345K
4
ZION icon
Zions Bancorporation
ZION
+$270K
5
TRV icon
Travelers Companies
TRV
+$244K

Sector Composition

Rank Sector Weight
1 Healthcare 20.64%
2 Financials 19.93%
3 Energy 16.63%
4 Industrials 13.42%
5 Consumer Discretionary 11.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRM icon
26
Iron Mountain
IRM
$36.4B
$1.42M 1.36%
26,902
+25
+0.1% +$1.31K
C icon
27
Citigroup
C
$222B
$1.38M 1.32%
29,377
+3,855
+15% +$189K
TFIN icon
28
Triumph Financial Inc
TFIN
$1.81B
$1.38M 1.32%
23,694
+9,520
+67% +$546K
TAK icon
29
Takeda Pharmaceutical
TAK
$54.6B
$1.36M 1.3%
82,235
– –
VTRS icon
30
Viatris
VTRS
$20.4B
$1.35M 1.3%
140,811
+22,088
+19% +$245K
RTX icon
31
RTX Corp
RTX
$290B
$1.35M 1.29%
13,767
-20
-0.1% -$1.97K
GT icon
32
Goodyear
GT
$2B
$1.27M 1.21%
115,105
+6,575
+6% +$72.9K
TROW icon
33
T. Rowe Price
TROW
$23.9B
$1.26M 1.21%
11,182
+5,823
+109% +$665K
GIS icon
34
General Mills
GIS
$19.1B
$1.23M 1.18%
14,398
-25
-0.2% -$2K
LMT icon
35
Lockheed Martin
LMT
$134B
$1.21M 1.16%
2,569
-4
-0.2% -$1.88K
OMF icon
36
OneMain Financial
OMF
$7.2B
$1.18M 1.13%
31,854
+1,955
+7% +$78.6K
AAPL icon
37
Apple
AAPL
$4.54T
$1.17M 1.12%
7,094
-80
-1% -$11.8K
GOOG icon
38
Alphabet (Google) Class C
GOOG
$4.36T
$1.16M 1.11%
11,135
-35
-0.3% -$3.38K
DVA icon
39
DaVita
DVA
$15.4B
$1.15M 1.1%
14,143
+4,411
+45% +$353K
BANC icon
40
Banc of California
BANC
$3.03B
$1.09M 1.04%
87,175
+1,125
+1% +$18.2K
CATC
41
DELISTED
CAMBRIDGE BANCORP
CATC
$1.08M 1.04%
16,704
+425
+3% +$32.9K
WRK
42
DELISTED
WestRock Company
WRK
$1.07M 1.02%
35,106
-3,360
-9% -$111K
DE icon
43
Deere & Co
DE
$160B
$1.05M 1%
2,540
– –
KMI icon
44
Kinder Morgan
KMI
$71.7B
$1.01M 0.97%
57,865
+2,550
+5% +$45.4K
CASH icon
45
Pathward Financial
CASH
$1.86B
$990K 0.95%
23,863
-40
-0.2% -$1.88K
CSCO icon
46
Cisco
CSCO
$457B
$978K 0.94%
18,712
– –
BF.B icon
47
Brown-Forman Class B
BF.B
$13.2B
$959K 0.92%
14,920
– –
CF icon
48
CF Industries
CF
$19.2B
$951K 0.91%
13,117
-10
-0.1% -$817
JPM icon
49
JPMorgan Chase
JPM
$935B
$901K 0.86%
6,914
-100
-1% -$13.7K
JNJ icon
50
Johnson & Johnson
JNJ
$618B
$864K 0.83%
5,573
– –
1
2
3 4 5

Similar funds

PFS
Prospect Financial Services Melville, New York $164M AUM 19.24% 1-Year Est. Return
CWR
Chico Wealth RIA Chico, California $164M AUM 24.86% 1-Year Est. Return
ACM
Alamar Capital Management Santa Barbara, California $164M AUM 19.77% 1-Year Est. Return
PWAM
Papamarkou Wellner Asset Management New York $164M AUM 25.23% 1-Year Est. Return
CCM
Clutterbuck Capital Management Cleveland, Ohio $164M AUM
GP
Gridiron Partners Wexford, Pennsylvania $164M AUM 3.31% 1-Year Est. Return
IPWA
International Private Wealth Advisors San Diego, California $163M AUM 16.99% 1-Year Est. Return
TCGDR
TB Capital Gestao de Recursos Rio De Janeiro $163M AUM 20.86% 1-Year Est. Return

Sippican Capital Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Sippican Capital Advisors held 104 positions worth $105M, up 0.06% from $105M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Sippican Capital Advisors's Q1 2023 filing shows 5 new, 26 increased, 40 reduced and 4 closed positions. Its largest new stake was Apellis Pharmaceuticals: 11,169 shares worth $737K. The largest sale was CVS Health, an estimated $640K.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Financials and Energy.

  • Sippican Capital Advisors's largest Q1 2023 buy was Apellis Pharmaceuticals: 11,169 shares worth $737K.
  • Sippican Capital Advisors added most to 3M in Q1 2023, an estimated $670K increase.
  • Sippican Capital Advisors's biggest Q1 2023 reduction was CVS Health, cutting an estimated $640K.
  • Sippican Capital Advisors fully exited Zions Bancorporation in Q1 2023, selling an estimated $270K.
  • Sippican Capital Advisors's ten largest holdings make up 26% of its $105M portfolio in Q1 2023.
  • Sippican Capital Advisors opened 5 new positions and closed 4 in Q1 2023.
  • Sippican Capital Advisors's portfolio value rose 0.06% quarter-over-quarter to $105M.

Based on Sippican Capital Advisors's 13F filing for Q1 2023, filed 14 Jul 2023.